Literature DB >> 24616100

Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2.

Yongtao Geng1, Yanfang Ju, Fangli Ren, Ying Qiu, Yasuhiko Tomita, Miki Tomoeda, Mioka Kishida, Yinyin Wang, Lian Jin, Fuqin Su, Chunhong Wei, Baoqing Jia, Yi Li, Zhijie Chang.   

Abstract

Wnt signaling plays a pivotal role in cell proliferation, tissue homeostasis, and tumorigenesis. Dishevelled (Dvl) is a central node of Wnt signaling. Insulin receptor substrates (IRSs), as a critical component of insulin signaling, are involved in cell proliferation, metabolism, and cancer development. In this study, we report that IRS1/2 promotes Wnt/β-catenin signaling by stabilizing Dvl2. We found that IRS1/2 interacts with Dvl2. Overexpression of IRS1/2 increased the protein level of Dvl2 and promoted canonical Wnt signaling, as evidenced by the increased T cell-specific factor 4 transcriptional activity and the up-regulation of expression of CYCLIN D1 and c-MYC, two Wnt target genes critical for cell growth, whereas depletion of IRS1/2 reduced the level of Dvl2 and attenuated Wnt/β-catenin signaling. Biochemical analyses revealed that IRS1/2 decreased Lys-63-linked ubiquitination of Dvl2 and stabilized Dvl2 protein via suppressing its autophagy-mediated degradation. We further revealed that IRS1/2 blocks autophagy-induced formation of the Dvl2-p62/SQSTM1 complex, resulting in disabled association of Dvl2 to autophagosomes. We demonstrated that IRS1/2 promoted the induction of epithelial-mesenchymal transition (EMT) and cell proliferation in response to Wnt stimulation, whereas depletion of Dvl2 impaired the IRS1/2-mediated EMT and cell growth. Our findings revealed that IRS1/2 promotes EMT and cell proliferation through stabilizing Dvl2.

Entities:  

Keywords:  Autophagy; Cell Proliferation; Dishevelled2; EMT; IRS; Wnt Signaling; β-Catenin

Mesh:

Substances:

Year:  2014        PMID: 24616100      PMCID: PMC4036261          DOI: 10.1074/jbc.M113.544999

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor.

Authors:  Yu Rong; Long Cheng; Hongxiu Ning; Jizhen Zou; Yuanjiang Zhang; Fang Xu; Li Liu; Zhijie Chang; Xin-Yuan Fu
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

Review 2.  Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2.

Authors:  Robert K Dearth; Xiaojiang Cui; Hyun-Jung Kim; Darryl L Hadsell; Adrian V Lee
Journal:  Cell Cycle       Date:  2007-03-20       Impact factor: 4.534

Review 3.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

4.  Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2.

Authors:  Robert K Dearth; Xiaojiang Cui; Hyun-Jung Kim; Isere Kuiatse; Nicole A Lawrence; Xiaomei Zhang; Jana Divisova; Ora L Britton; Syed Mohsin; D Craig Allred; Darryl L Hadsell; Adrian V Lee
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

5.  TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

Authors:  Ken Inoki; Hongjiao Ouyang; Tianqing Zhu; Charlotta Lindvall; Yian Wang; Xiaojie Zhang; Qian Yang; Christina Bennett; Yuko Harada; Kryn Stankunas; Cun-Yu Wang; Xi He; Ormond A MacDougald; Ming You; Bart O Williams; Kun-Liang Guan
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

6.  Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells.

Authors:  Ozlem Dalmizrak; An Wu; Jia Chen; Hongzhi Sun; Fransiscus E Utama; Diana Zambelli; Thai H Tran; Hallgeir Rui; Renato Baserga
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

7.  Wnt-dependent regulation of the E-cadherin repressor snail.

Authors:  Jong In Yook; Xiao-Yan Li; Ichiro Ota; Eric R Fearon; Stephen J Weiss
Journal:  J Biol Chem       Date:  2005-01-11       Impact factor: 5.157

8.  A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.

Authors:  Jong In Yook; Xiao-Yan Li; Ichiro Ota; Casey Hu; Hyun Sil Kim; Nam Hee Kim; So Young Cha; Joo Kyung Ryu; Yoon Jung Choi; Jin Kim; Eric R Fearon; Stephen J Weiss
Journal:  Nat Cell Biol       Date:  2006-10-29       Impact factor: 28.824

9.  Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells.

Authors:  Bin Shi; Laura Sepp-Lorenzino; Marco Prisco; Peter Linsley; Tiziana deAngelis; Renato Baserga
Journal:  J Biol Chem       Date:  2007-09-07       Impact factor: 5.157

10.  The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation.

Authors:  Stephane Angers; Chris J Thorpe; Travis L Biechele; Seth J Goldenberg; Ning Zheng; Michael J MacCoss; Randall T Moon
Journal:  Nat Cell Biol       Date:  2006-03-19       Impact factor: 28.824

View more
  27 in total

Review 1.  Stem cell guidance through the mechanistic target of rapamycin.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

2.  IGF-1R/β-catenin signaling axis is involved in type 2 diabetic osteoporosis.

Authors:  Zhi-Da Zhang; Hui Ren; Wei-Xi Wang; Geng-Yang Shen; Jin-Jing Huang; Mei-Qi Zhan; Jing-Jing Tang; Xiang Yu; Yu-Zhuo Zhang; Zhi-Dong Yang; Xiao-Bing Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

Review 3.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

Review 4.  The Mystery of Exosomes in Gestational Diabetes Mellitus.

Authors:  Tong Chen; Dan Liu
Journal:  Oxid Med Cell Longev       Date:  2022-06-08       Impact factor: 7.310

5.  T-cell factor (TCF/LEF1) binding elements (TBEs) of FasL (Fas ligand or CD95 ligand) bind and cluster Fas (CD95) and form complexes with the TCF-4 and b-catenin transcription factors in vitro and in vivo which result in triggering cell death and/or cell activation.

Authors:  Xia Liu; Yuwei Huang; Yuanyuan Zhang; Xiaohong Li; Chun Liu; Shen Huang; Dezhi Xu; Yang Wu; Xiaojuan Liu
Journal:  Cell Mol Neurobiol       Date:  2016-04-18       Impact factor: 5.046

Review 6.  Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.

Authors:  Kenneth Maiese
Journal:  Expert Rev Clin Pharmacol       Date:  2020-01-03       Impact factor: 5.045

Review 7.  The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins.

Authors:  Fumihiko Hakuno; Toshiaki Fukushima; Yosuke Yoneyama; Hiroyasu Kamei; Atsufumi Ozoe; Hidehito Yoshihara; Daisuke Yamanaka; Takashi Shibano; Meri Sone-Yonezawa; Bu-Chin Yu; Kazuhiro Chida; Shin-Ichiro Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-26       Impact factor: 5.555

Review 8.  Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease.

Authors:  Kenneth Maiese
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

Review 9.  Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT.

Authors:  Eugenio Zoni; Gabri van der Pluijm; Peter C Gray; Marianna Kruithof-de Julio
Journal:  J Oncol       Date:  2015-03-25       Impact factor: 4.375

10.  Decitabine reactivated pathways in platinum resistant ovarian cancer.

Authors:  Fang Fang; Qingyao Zuo; Jay Pilrose; Yinu Wang; Changyu Shen; Meng Li; Phillip Wulfridge; Daniela Matei; Kenneth P Nephew
Journal:  Oncotarget       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.